Stockreport

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Beta Bionics, Inc.  (BBNX) 
PDF IRVINE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, [Read more]